ECM
ZOM

ExodusPoint Capital Management’s Zomedica Corp. ZOM Stock Holding History

ExodusPoint Capital Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-171,703
Closed -$38K – 2503
2022
Q2 		$38K Buy
+171,703
New +$43.7K ﹤0.01% 1815
2021
Q2 		– Sell
-828,950
Closed -$1.31M – 3070
2021
Q1 		$1.31M Buy
+828,950
New +$1.35M 0.02% 766

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ExodusPoint Capital Management's ZOM Position: Q3 2022 in Review

ExodusPoint Capital Management sold out of Zomedica Corp. (ZOM) in Q3 2022, closing a stake of 171,703 shares — an estimated $38K sold.

ExodusPoint Capital Management first reported a position in ZOM in Q1 2021 and held it in 2 quarters. The position peaked at $1.31M in Q1 2021. 87 funds tracked by Wall St. Rank hold ZOM as of Q3 2022.

  • ExodusPoint Capital Management reported no remaining Zomedica Corp. position as of Q3 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 171,703 Zomedica Corp. shares in Q3 2022, an estimated $38K.
  • ExodusPoint Capital Management first reported a position in Zomedica Corp. in Q1 2021 and held it in 2 quarters.
  • ExodusPoint Capital Management's Zomedica Corp. position peaked at $1.31M in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.